CTHRC1 is associated with <i>BRAF</i>(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma
Rumeng Zhang(Sun Yat-sen University), Keshuo Ding(Anhui Medical University)
Cited by 5
Related Papers
GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis
|Journal of Biological Chemistry|2018|52